June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 25, 2025

Brain Tumors: Shining Light on the Latest Advances

The human brain — and its 86 billion neurons — controls complex movements, stores and receives memories, generates emotions and runs all of the body’s automatic functions simultaneously.

Baptist Health South Florida

June 24, 2025

X-ray Telescopes Detect Elusive “Missing” Intergalactic Matter

ESA and JAXA missions map faint X-ray emission across 23-million-light-year structure linking four galaxy clusters

The Analytical Scientist

June 19, 2025

AI Models Predict Lung Cancer Risk Better

A new review finds AI-based models more accurate than traditional regression models at predicting lung cancer risk, especially when using low-dose CT imaging data.

Conexiant

June 19, 2025

AI Models Predict Lung Cancer Risk Better

A new review finds AI-based models more accurate than traditional regression models at predicting lung cancer risk, especially when using low-dose CT imaging data.

Conexiant

June 06, 2025

FDA Monthly Round-up: Key May Updates

May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.

Conexiant

June 06, 2025

Tarlatamab Improves Survival in Resistant Lung Cancer

A multinational phase 3 trial found that tarlatamab significantly improved overall survival and reduced toxicity compared with standard chemotherapy in patients with small-cell lung cancer after progression on platinum-based therapy.

Conexiant

June 06, 2025

NRT’s Double-Edged Sword in Rectal Cancer

A large cohort study found neoadjuvant radiotherapy improved survival for rectal cancer patients but significantly increased the risk of permanent diverting stomas—especially in upper rectal tumors.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant